Skip to main content

Liver Metastases clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver

    Sorry, in progress, not accepting new patients

    The primary aim of this trial is to estimate the duration of hepatic progression-free survival (HPFS) in participants treated with bland embolization (BE), transcatheter arterial Lipiodol chemoembolization (TACE), and embolization by drug-eluting beads (DEB). The primary hypothesis is that chemoembolization will be nearly twice as durable as bland embolization; thatis, the hazard ratio for HPFS will be 1.76 or better.

    at UCSF

Our lead scientists for Liver Metastases research studies include .

Last updated: